These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 35924244)

  • 21. Novel Mutations in RASGRP1 are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma.
    Somekh I; Marquardt B; Liu Y; Rohlfs M; Hollizeck S; Karakukcu M; Unal E; Yilmaz E; Patiroglu T; Cansever M; Frizinsky S; Vishnvenska-Dai V; Rechavi E; Stauber T; Simon AJ; Lev A; Klein C; Kotlarz D; Somech R
    J Clin Immunol; 2018 Aug; 38(6):699-710. PubMed ID: 30030704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overview of secondary immunodeficiency.
    Herman KE; Tuttle KL
    Allergy Asthma Proc; 2024 Sep; 45(5):347-354. PubMed ID: 39294908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Progress on the diagnosis and therapy about atopic diseases and primary immunodeficiency diseases].
    Pan ZX; Xu YY; Bian SN; Li J; Jiang YL; Li J; Guan K
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Sep; 56(9):1218-1225. PubMed ID: 36207883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic Yield and Therapeutic Consequences of Targeted Next-Generation Sequencing in Sporadic Primary Immunodeficiency.
    Sogkas G; Dubrowinskaja N; Schütz K; Steinbrück L; Götting J; Schwerk N; Baumann U; Grimbacher B; Witte T; Schmidt RE; Atschekzei F
    Int Arch Allergy Immunol; 2022; 183(3):337-349. PubMed ID: 34619682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoimmune and Inflammatory Manifestations in 247 Patients with Primary Immunodeficiency-a Report from the Slovenian National Registry.
    Blazina Š; Markelj G; Jeverica AK; Toplak N; Bratanič N; Jazbec J; Kopač P; Debeljak M; Ihan A; Avčin T
    J Clin Immunol; 2016 Nov; 36(8):764-773. PubMed ID: 27582173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 7th International Immunoglobulin Conference: Immunodeficiencies.
    Schmidt RE; Ochs HD
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):3-4. PubMed ID: 25546741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies.
    Walter JE; Farmer JR; Foldvari Z; Torgerson TR; Cooper MA
    J Allergy Clin Immunol Pract; 2016; 4(6):1089-1100. PubMed ID: 27836058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the Effectiveness of the 6 Warning Signs of the European Society for Immunodeficiencies for Primary Immunodeficiencies in Older Adults.
    Yildiz E; Çölkesen F; Evcen R; Sadi Aykan F; Kılınç M; Arslan S
    Int Arch Allergy Immunol; 2024; 185(4):402-410. PubMed ID: 38219730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary immunodeficiencies associated with EBV-Induced lymphoproliferative disorders.
    Shabani M; Nichols KE; Rezaei N
    Crit Rev Oncol Hematol; 2016 Dec; 108():109-127. PubMed ID: 27931829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment.
    Seidel MG
    Blood; 2014 Oct; 124(15):2337-44. PubMed ID: 25163701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic and Predictive Contribution of Autoantibodies Screening in a Large Series of Patients With Primary Immunodeficiencies.
    Tahiat A; Yagoubi A; Ladj MS; Belbouab R; Aggoune S; Atek L; Bouziane D; Melzi S; Boubidi C; Drali W; Bendahmane C; Iguerguesdaoune H; Taguemount S; Soufane A; Oukil A; Ketfi A; Messaoudi H; Boukhenfouf N; Ifri MA; Bencharif Madani T; Belhadj H; Benhala KN; Khiari M; Cherif N; Smati L; Arada Z; Zeroual Z; Bouzerar Z; Ibsaine O; Maouche H; Boukari R; Djenouhat K
    Front Immunol; 2021; 12():665322. PubMed ID: 33868317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary immunodeficiencies (PIDs) presenting with cytopenias.
    Notarangelo LD
    Hematology Am Soc Hematol Educ Program; 2009; ():139-43. PubMed ID: 20008192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination in patients with primary immune deficiency, secondary immune deficiency and autoimmunity with immune regulatory abnormalities.
    Eibl MM; Wolf HM
    Immunotherapy; 2015; 7(12):1273-92. PubMed ID: 26289364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary Immunodeficiency Disorders Among North Indian Children.
    Gupta D; Thakral D; Kumar P; Kabra SK; Lodha R; Kumari R; Mohanty SK; Chakraborty S; Bagri N; Mitra DK
    Indian J Pediatr; 2019 Oct; 86(10):885-891. PubMed ID: 31177511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Developments in Primary Immunodeficiencies (PID)-a Rheumatological Perspective.
    Leavis H; Zwerina J; Manger B; Fritsch-Stork RDE
    Curr Rheumatol Rep; 2019 Sep; 21(10):55. PubMed ID: 31486986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell lymphoma with a granulomatous lesion of the lungs after autologous hematopoietic stem cell transplantation for Epstein-Barr virus-positive diffuse large B-cell lymphoma: a unique rare case of metachronous B-cell and T-cell lymphoma.
    Kajimoto Y; Terasaki Y; Terasaki M; Kunugi S; Okabe Y; Wakita S; Inokuchi K; Shimizu A
    Diagn Pathol; 2020 Oct; 15(1):125. PubMed ID: 33036636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The paradigm of hematological malignant versus non-malignant manifestations, driven by primary immunodeficiencies: a complex interplay.
    Kelaidi C; Tzotzola V; Polychronopoulou S
    Fam Cancer; 2021 Oct; 20(4):363-380. PubMed ID: 34128135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal system involvement in patients with primary immunodeficiency: a single center experience.
    Guler T; Kulhas Celik I; Ergani AC; Gumus M; Emiroglu HH; Artac H
    Scand J Gastroenterol; 2024 Sep; 59(9):1130-1136. PubMed ID: 39007903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genes at the Crossroad of Primary Immunodeficiencies and Cancer.
    Derpoorter C; Bordon V; Laureys G; Haerynck F; Lammens T
    Front Immunol; 2018; 9():2544. PubMed ID: 30443258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK.
    Shields AM; Anantharachagan A; Arumugakani G; Baker K; Bahal S; Baxendale H; Bermingham W; Bhole M; Boules E; Bright P; Chopra C; Cliffe L; Cleave B; Dempster J; Devlin L; Dhalla F; Diwakar L; Drewe E; Duncan C; Dziadzio M; Elcombe S; Elkhalifa S; Gennery A; Ghanta H; Goddard S; Grigoriadou S; Hackett S; Hayman G; Herriot R; Herwadkar A; Huissoon A; Jain R; Jolles S; Johnston S; Khan S; Laffan J; Lane P; Leeman L; Lowe DM; Mahabir S; Lochlainn DJM; McDermott E; Misbah S; Moghaddas F; Morsi H; Murng S; Noorani S; O'Brien R; Patel S; Price A; Rahman T; Seneviratne S; Shrimpton A; Stroud C; Thomas M; Townsend K; Vaitla P; Verma N; Williams A; Burns SO; Savic S; Richter AG
    Clin Exp Immunol; 2022 Sep; 209(3):247-258. PubMed ID: 35641155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.